Skip to content

Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps

Eyal Kurzbaum, Tomáš Páleníček, Amiel Shrchaton, Yaron Dekel, Sara P. Azerrad

Journal of Fungi January 28, 2025 DOI: 10.3390/jof11020099 via OpenAlex

Summary

AI-generated from the abstract

The psychoactive mushroom Psilocybe cubensis, known for its historical and modern therapeutic roles, shows substantial variability in its psychoactive compounds, psilocybin and psilocin, due to genetic diversity, strain differences, and environmental factors. Advances in cultivation, such as submerged fermentation of mycelium, and improved analytical methods now allow more precise compound quantification and extraction. Despite nearly four decades of regulatory restrictions limiting scientific information, recent genetic and biochemical studies are beginning to reveal insights into its therapeutic potential. The review identifies key knowledge gaps and suggests future research directions to improve cultivation, document strain diversity, and address regulatory and therapeutic uses.

Study at a glance

Characteristics Review Peer reviewed
Topics Psilocybin
Keywords Biology Biotechnology Documentation
Citations 11
Key finding Genetic diversity, strain variability, and environmental factors shape the biosynthesis of psilocybin and psilocin in Psilocybe cubensis, and recent advances in cultivation and analytical methods are beginning to clarify its therapeutic potential despite decades of regulatory restrictions.

Abstract

Psilocybe cubensis, a widely recognized psychoactive mushroom species, has played a significant role in both historical and modern therapeutic practices. This review explores the complex interplay between genetic diversity, strain variability and environmental factors that shape the biosynthesis of key psychoactive compounds, including psilocybin and psilocin. With many strains exhibiting substantial variability in their phenotypic characteristics and biochemical content, understanding and documenting this diversity is crucial for optimizing therapeutic applications. The review also highlights advances in cultivation techniques, such as submerged fermentation of the mycelium, and innovative analytical methodologies that have improved the precision of compound quantification and extraction. Although there is limited scientific information on P. cubensis due to nearly four decades of regulatory restrictions on psychedelic research, recent developments in genetic and biochemical studies are beginning to provide valuable insights into its therapeutic potential. Furthermore, this review emphasizes key knowledge gaps and offers insights into future research directions to advance the cultivation, scientific documentation of strain diversity, regulatory considerations and therapeutic use of P. cubensis.

Explore topics

Comments

No comments yet.

Log in to comment